Vaer Report Details
Age: NA
Gender: Male
State: Outside US
- Patient Died?
- No
- Vaccine information
-
Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Type: Coronavirus 2019 vaccine
Manufacturer: PFIZER
Lot: fh9951
- Date report was received
- 2022-03-04
- Date form completed
- Date Vaccinated
- 2021-10-26
- Date of Onset
- 1
- Number of days (onset date – vaccination date)
- 1
- Adverse Event Description
-
hospitalization for transient ischemic attack. 4 days after the administration of the vaccine dose (after sars-cov-2 infection, which occurred previously, with hospitalization, for 14 days.; fever; headache; myalgia; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: it-minisal02-842738. a 43 year-old male patient received bnt162b2 (comirnaty), intramuscular, administered in arm right, administration date 26oct2021 (lot number: fh9951) as dose 1,single for covid-19 immunisation. relevant medical history included: "covid 19", start date: may2021 (unknown if ongoing), notes: for which he was hospitalized from 12may2021 to 26may2021; "bronchial asthma" (unknown if ongoing); "anxiety" (unspecified if ongoing). concomitant medication(s) included: xanax taken for anxiety. the following information was reported: transient ischaemic attack (hospitalization, life threatening) with onset 27oct2021, outcome "not recovered", described as "hospitalization for transient ischemic attack. 4 days after the administration of the vaccine dose (after sars-cov-2 infection, which occurred previously, with hospitalization, for 14 days."; pyrexia (life threatening) with onset 27oct2021, outcome "not recovered", described as "fever"; headache (life threatening) with onset 27oct2021, outcome "not recovered", described as "headache"; myalgia (life threatening) with onset 27oct2021, outcome "not recovered", described as "myalgia". the patient was hospitalized for transient ischaemic attack (start date: 30oct2021, discharge date: 31oct2021, hospitalization duration: 1 day(s)). therapeutic measures were taken as a result of transient ischaemic attack. additional information: actions taken (currently undergoing anticoagulant therapy since the day of admission for ra) - impact on quality of life (10/10). start date of therapy for ra (cardioaspirin 100 mg tablets since 30oct2021 to date). patient was admitted to the hospital since 30oct2021 to 31oct2021. reporter comment: patient suffering from bronchial asthma, about to make further visits to confirm what was already highlighted by the national health service years ago and to be treated again for this pathology. no follow-up attempts are completed. no further information is expected.; reporter's comments: patient suffering from bronchial asthma, about to make further visits to confirm what was already highlighted by the national health service years ago and to be treated again for this pathology
- Lab Data
-
na
- List of symptoms
-
headache pyrexia myalgia transient ischaemic attack
- Patient Died?
- No
- Date Died
- NA
- Birth defect
- false
- Vaccine Administered By:
- Other
- Vaccine Purchased By:
- Unknown
- Patient visit ER?
- No
- Patient Hospitalized?
- Yes
- Stay in hospital
- No
- Days in hospital
- Unspecified
- Permanent disability?
- No
- Allergies:
-
na
- Current Illness
-
na